Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Solid Tumor × Radiomics × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Radiomics 1 Pituitary Diseases 1 Neuroendocrine Tumors 1 Neoplasms 1 Liver Cirrhosis 1 Hepatitis B 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Bone Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Fluorodeoxyglucose F18 3 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 Tegafur 1 Surveys and Questionnaires 1 Specimen Handling 1 S 1 (combination) 1 Radiomics 1 Proton Therapy 1 Postmortem Imaging 1 PMEPA1 protein, human 1 Off-Label Use 1 Latent Class Analysis 1 Immunohistochemistry 1 Hepatitis B Vaccines 1 Fluorouracil 1 Capecitabine 1 Blood Specimen Collection 1 Blood Component Removal 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04079283 2020-04-02

RIREP

Tianjin Medical University Cancer Institute and Hospital

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡